Masimo Corporation (NASDAQ:MASI) EVP Yongsam Lee sold 5,000 shares of the stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $89.89, for a total value of $449,450.00. Following the completion of the sale, the executive vice president now directly owns 74,000 shares of the company’s stock, valued at $6,651,860. The sale was disclosed in a filing with the SEC, which is available at this link.
Masimo Corporation (NASDAQ:MASI) traded down $1.93 on Friday, hitting $86.00. The stock had a trading volume of 333,270 shares, compared to its average volume of 384,306. The company has a market capitalization of $4.37 billion, a PE ratio of 32.37, a P/E/G ratio of 2.84 and a beta of 0.75.
Masimo Corporation (NASDAQ:MASI) last posted its quarterly earnings results on Tuesday, October 31st. The medical equipment provider reported $0.70 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.53 by $0.17. Masimo Corporation had a return on equity of 22.17% and a net margin of 45.83%. The company had revenue of $193.69 million during the quarter, compared to the consensus estimate of $189.01 million. During the same period last year, the business earned $0.52 EPS. The business’s quarterly revenue was up 15.6% on a year-over-year basis. equities research analysts anticipate that Masimo Corporation will post 2.96 EPS for the current year.
COPYRIGHT VIOLATION WARNING: This news story was originally published by Community Financial News and is owned by of Community Financial News. If you are accessing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark law. The correct version of this news story can be viewed at https://www.com-unik.info/2017/11/04/masimo-corporation-masi-evp-yongsam-lee-sells-5000-shares-of-stock.html.
Several equities research analysts recently issued reports on MASI shares. Roth Capital increased their price objective on Masimo Corporation from $96.00 to $105.00 and gave the stock a “buy” rating in a research note on Wednesday, July 19th. Stifel Nicolaus started coverage on Masimo Corporation in a research note on Monday, July 10th. They issued a “buy” rating and a $105.00 price objective for the company. Zacks Investment Research raised Masimo Corporation from a “sell” rating to a “hold” rating in a research note on Tuesday, July 11th. BidaskClub raised Masimo Corporation from a “hold” rating to a “buy” rating in a research note on Wednesday, July 12th. Finally, BTIG Research raised Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price objective for the company in a research note on Monday, August 14th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and five have given a buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $97.17.
Several institutional investors and hedge funds have recently bought and sold shares of MASI. BlackRock Inc. raised its stake in shares of Masimo Corporation by 7.5% during the 2nd quarter. BlackRock Inc. now owns 7,915,230 shares of the medical equipment provider’s stock worth $721,710,000 after purchasing an additional 550,995 shares in the last quarter. Koch Industries Inc. raised its stake in shares of Masimo Corporation by 5,053.7% during the 2nd quarter. Koch Industries Inc. now owns 443,939 shares of the medical equipment provider’s stock worth $439,000 after purchasing an additional 435,325 shares in the last quarter. State Street Corp raised its stake in shares of Masimo Corporation by 42.8% during the 1st quarter. State Street Corp now owns 1,401,516 shares of the medical equipment provider’s stock worth $130,704,000 after purchasing an additional 419,767 shares in the last quarter. Acadian Asset Management LLC raised its stake in shares of Masimo Corporation by 28.0% during the 2nd quarter. Acadian Asset Management LLC now owns 1,791,597 shares of the medical equipment provider’s stock worth $163,356,000 after purchasing an additional 392,410 shares in the last quarter. Finally, JPMorgan Chase & Co. raised its stake in shares of Masimo Corporation by 76.3% during the 2nd quarter. JPMorgan Chase & Co. now owns 802,698 shares of the medical equipment provider’s stock worth $73,191,000 after purchasing an additional 347,360 shares in the last quarter. 82.96% of the stock is owned by institutional investors.
About Masimo Corporation
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
What are top analysts saying about Masimo Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Masimo Corporation and related companies.